Last updated on April 2019

Addressing Dementia Via Agitation-Centered Evaluation


Brief description of study

This is a multi-center, randomized, double-blind, placebo-controlled study, to assess the efficacy and safety of AXS-05 in the treatment of agitation in patients with Alzheimer's disease.

Clinical Study Identifier: NCT03226522

Contact Investigators or Research Sites near you

Start Over

Axsome study site

New York, NY United States
6.78miles
  Connect »

Axsome study site

Brooklyn, NY United States
9.92miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.